HCW BiologicsHCWB
13F holders, Q3 2025 (September 30)10holders +2
4new positions
2sold out
$3.70avg. 13F price*
At the end of Q3 2025, 10 institutions reported holding HCW Biologics Inc. (HCWB) in their 13F filings, up 2 from Q2 2025. 4 opened new positions and 2 sold out. The largest holders were DRW Securities, LLC ($309K), Vanguard Group Inc. ($57K) and Geode Capital Management, LLC ($41K).
- Company
- HCW Biologics Inc.
- CUSIP
- 40423R204
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $408K |
| Exits | 2 | $38K |
All 13F filers, Q2 2025 → Q3 2025: 111,486 shares bought and 9,581 shares sold, net +101,905 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| DRW Securities, LLC | 0.02% | New | 83,436 | $309K |
| Vanguard Group Inc. | 0.00% | New | 15,426 | $57K |
| Geode Capital Management, LLC | 0.00% | New | 11,001 | $41K |
| Golden State Wealth Management, LLC | 0.00% | No change | 10,000 | $37K |
| Wells Fargo & Company | 0.00% | No change | 1,700 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +524.8% | 1,562 | $6K |
| Citigroup Inc. | 0.00% | New | 311 | $1K |
| Osaic Holdings, Inc. | 0.00% | No change | 26 | $96 |
| Bank of America Corp. | 0.00% | No change | 10 | $37 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -83.3% | 1 | $4 |
"% of holder's portfolio" is HCWB's weight in each manager's 13F, not the share of HCW Biologics Inc. the manager owns.